Skip to main content
Log in

Ethical considerations of researchers conducting pediatric clinical drug trials: a qualitative survey in two Belgian university children’s hospitals

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

There is a general consensus about the underlying theoretical ethical principles that ground the practice of pediatric clinical trials: scientific necessity, good risk/benefit ratio, minimized burden, and parental consent/child assent. However, these principles are so broadly construed that it is not always clear how they should be applied in clinical practice. We conducted a qualitative study at Ghent University Hospital and the hospital of the Dutch-speaking university of Brussels on how researchers weigh ethical principles, assess the risk/benefit balance, estimate patient experience, and experience informed consent procedures in pediatric drug studies. Based on our assessment of the burden and risk versus benefit ratio in 62 pediatric drug research protocols, we selected 21 studies for further study to maximize diversity. Twenty-seven researchers (17 physicians, 10 study nurses) completed a qualitative survey about their study. We compared their responses to our assessments. The risk benefit assessment of our participants about their own research projects resembled our assessment almost perfectly. Assessing burden appeared to be more subjective. The researchers were confident in their ability to obtain valid consent. However, we question whether this confidence is warranted.

Conclusion: We argue for constant ethical reflexivity in pediatric clinical trials, because broad ethical principles are not always easy to apply to specific situations.

What is Known:

Several international guidelines and a large body of scientific literature indicate a broad consensus about the basic ethical framework for pediatric clinical trials, based on risk benefit assessment and respect for autonomy.

Little is known about how researchers implement these broad principles in practice.

What is New:

Researchers’ risk/benefit assessments about their own studies resembled the assessment of neutral peers, assessing burden was more subjective.

Researchers were very confident in their ability to obtain valid informed consent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Afshar R, Lodha A, Costei A, Vaneyke N (2005) Recruitment in pediatric clinical trials: an ethical perspective. J Urol 174:835–840

    Article  PubMed  Google Scholar 

  2. Bos W, Tromp K, Tribboel D, Pinxten W (2013) Educational paper: ethical aspects of clinical research with minors. Eur J Pediatr 172:859–866

    Article  PubMed  Google Scholar 

  3. Dekking SAS, van der Graaf R, van Delden JJM (2014) Strengths and weaknesses of guideline approaches to safeguard voluntary informed consent of patients within a dependent relationship. BMC Med 12:52–63

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gibson BE, Stasiulis E, Gutfreund S, McDonald M, Dade L (2011) Assessment of children’s capacity to consent for research: a descriptive qualitative study of researchers’ practices. J Med Ethics 37:504–509

    Article  PubMed  Google Scholar 

  5. Giesbertz N, Bredenoord AL, van Delden JJM (2014) Clarifying assent in pediatric research. Eur J Hum Genet 22:266–269

    Article  PubMed  Google Scholar 

  6. Jansen H (2010) The logic of qualitative survey research and its position in the field of social research methods. Forum Qual Soc Res 11(2):1–14

    Google Scholar 

  7. Laventhal N, Tarini BA, Lantos J (2012) Ethical issues in neonatal and pediatric clinical trials. Pediatr Clin N Am 59:1205–1220

    Article  Google Scholar 

  8. Pinxten W, Nys H, Dierickx K (2008) Regulating trust in pediatric clinical trials. Med Health Care Philos 11:439–444

    Article  PubMed  Google Scholar 

  9. Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM (2011) Ethical considerations in conducting pediatric research. In: Seyberth HW, Rane A, Schwab M (eds) Pediatric clinical pharmacology. Springer, Heidelberg, pp 219–244

    Chapter  Google Scholar 

  10. Sammons HM, Starkey ES (2012) Ethical issues of clinical trials in children. J Paediatr Child Health 22(2):47–50

    Article  Google Scholar 

  11. Shah S, Whittle A, Wilfond B, Gensler G, Wendler D (2004) How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA 291(4):476–482

    Article  PubMed  CAS  Google Scholar 

  12. Vanhelst J, Hardy L, Bert D, Duhem S, Coopman S, Libersa C, Deplanque D, Gottrand F, Béghin L (2013) Effect of child health status on parents’ allowing children to participate in pediatric research. BMC Med Ethics 14:7–16

    Article  PubMed  PubMed Central  Google Scholar 

  13. Westra AE, Wit JM, Sukhai RN, de Beaufort I (2011) How best to define the concept of minimal risk. J Pediatr 159(3):496–500

    Article  PubMed  Google Scholar 

  14. Woods S, Hagger LE, McCormack P (2014) Therapeutic misconception: hope, trust and misconception in paediatric research. Health Care Anal 22:3–21

    Article  PubMed  Google Scholar 

  15. Wulf F, Krasuska M, Bullinger M (2012) Determinants of decision-making and patient participation in paediatric clinical trials: a literature review. Open J Pediatr 2:1–17

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge the SAFEPEDRUG consortium for their progressive attitude towards pediatric clinical trials.

Funding

This study was supported by the “Agency for Innovation by Science and Technology in Flanders (IWT)” through the SAFEPEDRUG project (IWT/SBO 130033).

Author information

Authors and Affiliations

Authors

Contributions

PDB and JVdW wrote the grant proposal; WVH, KM, LD, and DC gathered the data; WVH, KM, and LD analyzed the data; WVH drafted the text; and all authors revised the text.

Corresponding author

Correspondence to Wannes Van Hoof.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Communicated by Mario Bianchetti

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Hoof, W., Meesters, K., Dossche, L. et al. Ethical considerations of researchers conducting pediatric clinical drug trials: a qualitative survey in two Belgian university children’s hospitals. Eur J Pediatr 177, 1003–1008 (2018). https://doi.org/10.1007/s00431-018-3151-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-018-3151-9

Keywords

Navigation